TP can improve lipid deposition and oxidative stress in the chronic alcoholic liver by reducing the expression of the FAT/CD36 protein in hepatocyte membranes, intervening in ALD [23] and reducing intracellular ROS levels to alleviate stem cell steatosis [24]. The gene discussed is CD36; the disease is digestive system neoplasm.